Author: Isabel Rollandi

Zynga Inc (NASDAQ:ZNGA)’s Director, Sunil Paul, has reported the acquisition of 19,654 Class A Common Stock, as a conversion of derivative security. After this transaction Mr. Paul holds, directly, 142,943 shares at this $ 2.62 Billion Market Cap Company. Insider have been active selling shares of this stock over the course of this year. General Counsel, Sec. And Vp Devang Shah sold 39,189 shares, at prices ranging from $ 2.86 to $ 5.06 per share; Director Stanley Meresman sold another 8,333 shares, at prices ranging from $ 3.50 to $ 5.58 each share; and Director and Large Shareholder  William Gordon sold an…

Read More

Baker Jessica Flechtner, Vp of Research at Genocea Biosciences Inc (NASDAQ:GNCA), has recently reported a series of transactions regarding this stock. Mrs. Flechtner acquired 8,115 shares of common stock, at prices ranging from $ 2.38 to $ 1.67 per share, as exercise or conversion of derivative security exempted pursuant to Rule 16b-3. In addition, Mrs. Flechtner sold 6,435 company shares, at an average weighted Price of $ 12 per share. Following these transactions, Mrs. Flechtner holds 1,680 shares, in a direct form. During 2014, important company insiders have traded this stock. Directors Kevin Bitterman, Simeon George  and Stephen Hoffman have purchased,…

Read More

Paul Hoenmans, Director at Cheniere Energy, Inc. (NYSEMKT:LNG), has recently reported the acquisition of 1,081 shares of common stock, issued as a restricted stock grant. Therefore no consideration was given by Mr. Hoenmans. Following this transaction, Mr. Hoenmans owns 103,914 securities in a direct form. Over the course of this year, other insider transactions have been reported at this $ 19.67 Billion Market Cap Company. Senior Vp – international at Cheniere Energy, Inc. (NYSEMKT:LNG),  Jean Abiteboul sold 150,000 shares, at prices ranging from $ 45.32 to $ 72.85 per share, and Senior Vp and General Counsel Greg Rayford, by his part, sold 114,000…

Read More

Executive Chairman, Emea at CBRE Group Inc (NYSE:CBG) Michael Strong sold 36,358 shares of Class A common Stock, at an average price of  $ 30.52 per share. Following this transaction, Mr. Strong owns 204,991 securities at this $ 9.98 Billion Market Cap company, in a direct form. This isn’t the first sell Mr. Strong has made over the course of 2014. During Q2, 2014, he sold 20,000 shares of stock, at a price of $ 29.94 per share. Other important insider sells have been reported at CBRE Group Inc (NYSE:CBG) during 2014. Gil Borok Dpty Cfo & Chief Officer sold 30,000 shares, at a…

Read More

Corporate Controller at Mentor Graphics Corp (NASDAQ:MENT), Richard Trebing, received 2,377 company shares, as an exercise or conversion of derivative security exempted pursuant to Rule 16b-3. Moreover, Mr. Trebing sold another 865 shares of common stock, at an average price of $ 22.10 per share. The transaction was effected under SEC code F: “Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3,” (SEC). Following the reported transactions, Mr. Trebing holds 5,702 shares at this Company, with a $ 2.51 Billion Market…

Read More

T. William Camp E.v.p. & Cfo at Washington Real Estate Investment Trust (NYSE:WRE) has reported selling 11,000 shares of common stock, at prices ranging from $ 27.22 to $ 26.52 per share. Following this transaction, Mr. Camp holds 61,168 shares in a direct form at this $ 1.76 Billion Market Cap Company. Over the course of 2014, other insider sells at the company have been registered. During Q2, Sr. V.p. – Property Operations Bradley James Cederdahl, E.v.p. Accounting, Laura Franklin, and Sr. V.p. – Acquisitions Thomas Regnell, reported selling, respectively, 1,000 shares of common stock, at a price of $ 24.48 per share,…

Read More

Steiner Leisure Ltd (NASDAQ:STNR)’s President and Coo Glenn Fusfield reported selling 3,282 shares of common stock, at prices ranging from $ 40 and $ 39.54 per share. After this transaction, Mr. Fusfield holds 15,881 securities in a direct form at this $ 559.89 Million Market Cap Company. The reported sell isn’t the first one to be made by President Fusfield over the course of this year. During Q1, Mr. Fusfield sold 6,010 shares of common company stock, at an average Price of $ 45.00 per share, and during Q2, he reported selling 5,300 company shares, at a price of $ 42.50 each share.…

Read More

Timothy Mclevish, Director at Kennametal Inc. (NYSE:KMT), recently reported the acquisition of 18,000 shares of Common Stock, at a Price of $ 25.43 per share. The transaction was made as exercise or conversion of derivative security exempted pursuant to Rule 16b-3. Following this transaction, Mr. Mclevish owns 41,290 at this $ 3.40 Billion Market Cap Company, in a direct form. This is the first insider transaction effected in four years. Moreover, important hedge funds are attracted by this supplier of tooling, engineered components and advanced materials company. Chuck Royce’s Royce & Associates currently holds more than 3.4 million shares at…

Read More

Cbo & Sr Vp at Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Richard Thomas Kassberg, has recently reported selling 3,333 shares of common stock, at a price of $ 54.82 per share. Following this transaction, Mr. Kassberg directly holds 102,471 securities at this $ 1.83 Billion Market Cap Company. These sales were effected under a trading plan adopted by Mr. Kassberg, pursuant to Rule 10b5-1. This isn’t the first sell pursued by Mr. Kassberg over the course of this year. Cbo & Senior VP reported selling another 20,000 shares of this stock, at prices ranging from $ 55.00 to $ 52.82, during first…

Read More

Chief Financial Officer at Avago Technologies Ltd (NASDAQ:AVGO), Anthony Maslowski, has recently purchased 5,000 shares of common company stock, at a price of $ 20.08 per share. In addition, Mr. Maslowski also reported selling another 5,000 shares of common stock, at a price of $ 88.15 per share. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Maslowski on December 22, 2011. Moreover, Chief Financial Officer also reported selling 5,729 securities, at a price of $ 87.96 per share. These shares “were sold pursuant to an irrevocable election of the Reporting Person, dated June 18, 2013,…

Read More

Seven insiders at DexCom, Inc. (NASDAQ:DXCM) have recently performed transactions at the company. Richard Doubleday, Sr. Vp. Worldwide Sales at DexCom, Inc. sold 2,228 shares of Common Stock, at a Price of $ 43.23 per share. Following this transaction, Mr. Doubleday owns 124,354 shares at the Company, in a direct form. Sr. Vp, General Counsel, John Lister, sold another 2,879 shares of common stock at the same price, and currently holds, directly, 109,676 securities at the company. Moreover, Vp and Cfo Jess Roper reported selling 2,228 securities at the company, at a Price of $ 43.23 per share. Currently, Mr. Roper owns 85,985 shares at the company, in…

Read More

Jeffrey Eberwein, Director and Large Shareholder at Crossroads Systems Inc. (NASDAQ:CRDS), has recently acquired company shares. He boosted 15,000 shares of common stock, at prices ranging from $ 2.67 to $ 2.72 per share. This purchase was effected pursuant to a Rule 10b5-1 trading plan entered into by Lone Star Value Investors, LP on June 17, 2014. Following the reported transaction, Mr. Eberwein holds 2,237,052 shares at the company, in an indirect form, by Lone Star Value Investors, LP, from which Mr. Eberwein is the managing member. “Mr. Eberwein disclaims beneficial ownership of these shares of the Issuer’s common stock…

Read More